Eugene Gabianelli, MD
Ophthalmology · Atlanta, GANPI 1104838697
Payments from drug & device makers
Across 124 payments — averaging $41.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- NEW World Medical,inc.$2K
- Alcon$1K
- AbbVie$582
- Sun Pharmaceutical Industries Inc.$378
- Eyepoint US, Inc.$250
- Novartis$184
- plus $757 from 19 others
What the payments were for
- Food & beverage$3,51697%
- Education$1003%
- Gifts$170%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| NEW World Medical,inc. | 1 | $1,500 |
| Alcon | 47 | $1,483 |
| AbbVie(2 entities) | 21 | $582 |
| Sun Pharmaceutical Industries Inc. | 18 | $378 |
| Eyepoint US, Inc. | 2 | $250 |
| Novartis | 9 | $184 |
| Rxsight Inc | 1 | $138 |
| Mallinckrodt Hospital Products Inc. | 2 | $124 |
| Omeros Corporation | 1 | $57 |
| Kala Pharmaceuticals, Inc. | 3 | $55 |
| Johnson & Johnson Surgical Vision, Inc. | 3 | $48 |
| Aerie Pharmaceuticals, Inc. | 2 | $39 |
| Bausch & Lomb Americas Inc. | 2 | $39 |
| Tarsus Pharmaceuticals, Inc. | 1 | $36 |
| Lensar, Inc. | 1 | $35 |
| Amgen | 1 | $25 |
| Dompe US, Inc. | 1 | $21 |
| Harrow Eye, LLC | 1 | $20 |
| Ocular Therapeutix, Inc. | 1 | $20 |
| Biotissue Holdings Inc. | 1 | $17 |
| Carl Zeiss Meditec, Inc. | 1 | $17 |
| Sight Sciences, Inc. | 1 | $17 |
| Mallinckrodt Enterprises LLC | 1 | $17 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $17 |
| Oyster Point Pharma, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,133 in reported general payments places this provider in the 70th percentile of 481 ophthalmology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 84 | $2,665 |
| Brimonidine Tartrate | 24 | $1,309 |
| Latanoprost | 41 | $668 |
| MoxifloxacinMoxifloxacin Hcl | 24 | $402 |
| Ketorolac Tromethamine | 34 | $310 |
| Timolol Maleate | 11 | $117 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Atlanta
- Douglas DayAtlanta$1.1M
- Thomas AabergAtlanta$959K
- Gagan SawhneyAtlanta$874K
- Lawrence WoodardAtlanta$578K
- Stephanie VanderveldtAtlanta$384K
- Steven YehAtlanta$289K
- Atul SharmaAtlanta$193K
- Chris BergstromAtlanta$139K
- Anastasios CostaridesAtlanta$137K
- Evan SchoenbergAtlanta$130K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.